TriGemX Bio closes a $94 million financing round co-led by The Column Group, TCGX, and Viking Global Investors to advance phase 3 trials for their migraine treatment elismetrep.
Amount Raised
$94 Million
Round Type
Venture
Investors
Description
TriGemX Bio, a biotechnology company focused on migraine treatments, has announced the closing of a $94 million financing. The funding will support the clinical development of elismetrep, their lead program. The round was co-led by The Column Group, TCGX, and Viking Global Investors, with additional participation. This financing marks a significant step toward advancing their innovative treatment.
Quick answer
TriGemX Bio raised $94 Million in a funding round, dated October 1, 2026. Investors: Viking Global Investors, The Column Group and Tcgx. TriGemX Bio is based in New York, New York, United States.
- How much did TriGemX Bio raise?
- TriGemX Bio raised $94 Million in a funding round on October 1, 2026.
- Who invested in TriGemX Bio?
- Viking Global Investors, The Column Group and Tcgx are named as investors in this round.
- What does TriGemX Bio do?
- TriGemX Bio is a biotechnology company focused on developing a first-in-class medicine for the treatment of migraine.
- Where is TriGemX Bio based and how big is it?
- TriGemX Bio is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as TriGemX Bio that raised within 45 days of this round, from Fundz verified event records.
- Yicura BioMed raised an undisclosed amount (Series B) on November 13, 2026.
- Boston Medical Sciences raised $35M (Series B) on November 13, 2026.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
- Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
Who to call at TriGemX Bio, and when
A new round usually means TriGemX Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TriGemX Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TriGemX Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TriGemX Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TriGemX Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TriGemX Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.